Retrophin

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Retrophin and buy or sell other stocks, ETFs, and their options commission-free!

About RTRX

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. 

CEO
Eric M. Dube, PhD
CEOEric M. Dube, PhD
Employees
385
Employees385
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2008
Founded2008
Employees
385
Employees385

RTRX Key Statistics

Market cap
1.72B
Market cap1.72B
Price-Earnings ratio
-5.99
Price-Earnings ratio-5.99
Dividend yield
—
Dividend yield—
Average volume
2.07M
Average volume2.07M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$25.29
52 Week high$25.29
52 Week low
$6.01
52 Week low$6.01

People also own

Based on the portfolios of people who own RTRX. This list is generated using Robinhood data, and it’s not a recommendation.
Aurora Cannabis
Meta Platforms
Inovio
GE
Corbus Pharmaceuticals
Snap
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.